VanEck Pharmaceutical ETF Rating $87.08 -0.36 (-0.41%) (As of 10:17 AM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.72Holdings in PPH have an aggregate rating of Moderate Buy based on 248 analyst ratings issued in the past year covering 22 companies (90.1% of the portfolio).PPH Aggregate Price Target$87.08High Prediction$87.08Average Prediction$87.08Low Prediction$87.08Holdings in PPH have an aggregate price target of $87.08 and a range of $87.08 to $87.08 covering 22 companies (90.1% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.27%LLYEli Lilly and Company$743.60-1.3%4.9913 of 5 stars2.81$1,007.94 35.5%21Analyst Revision7.96%NVONovo Nordisk A/S$102.22-2.9%4.232 of 5 stars2.86$144.50 41.4%7Options Volume6.60%JNJJohnson & Johnson$153.24+0.1%4.9639 of 5 stars2.53$175.94 14.8%15Positive News5.95%BMYBristol-Myers Squibb$57.97+0.2%4.7873 of 5 stars2.20$54.07 -6.7%20Analyst Revision5.91%MCKMcKesson$624.38+0.5%4.8017 of 5 stars2.94$631.57 1.2%16Positive News5.76%ABBVAbbVie$167.90+0.1%4.9624 of 5 stars2.90$203.37 21.1%21Analyst ForecastPositive News5.10%CORCencora$242.55-0.3%4.875 of 5 stars2.73$271.20 11.8%11Positive News4.80%MRKMerck & Co., Inc.$97.56+0.1%4.9964 of 5 stars2.68$130.86 34.1%19Dividend IncreasePositive News4.55%ZTSZoetis$175.87+0.1%4.8598 of 5 stars3.10$221.44 25.9%10Positive News4.44%AZNAstraZeneca$63.81+1.0%3.9864 of 5 stars2.92$89.75 40.7%12Analyst UpgradeAnalyst Revision4.41%HLNHaleon$9.56+0.8%4.0139 of 5 stars3.00$10.95 14.5%6Positive News4.34%PFEPfizer$24.84-0.4%5 of 5 stars2.50$32.92 32.5%16Analyst DowngradeAnalyst RevisionNews Coverage4.12%SNYSanofi$47.72-0.1%2.8128 of 5 stars2.75$57.50 20.5%4Analyst Revision3.89%GSKGSK$33.31-0.1%4.4152 of 5 stars2.60$43.25 29.8%10Options VolumeAnalyst Revision3.64%TEVATeva Pharmaceutical Industries$17.06+0.2%2.7027 of 5 stars2.78$19.67 15.3%92.17%VTRSViatris$13.16+0.2%1.3514 of 5 stars2.00$13.33 1.3%31.15%JAZZJazz Pharmaceuticals$120.63+1.2%4.9183 of 5 stars2.80$175.33 45.3%15Analyst Forecast1.12%CTLTCatalent$59.03+0.1%3.0395 of 5 stars2.00$63.40 7.4%70.67%ELANElanco Animal Health$13.47+0.2%4.1237 of 5 stars2.43$17.14 27.3%70.57%OGNOrganon & Co.$14.85+0.8%4.7298 of 5 stars2.50$21.33 43.7%40.49%PRGOPerrigo$26.92-0.8%4.9834 of 5 stars2.75$37.00 37.4%4News CoveragePositive News0.22%PDCOPatterson Companies$20.04-0.1%4.8244 of 5 stars2.27$28.30 41.2%11 This page (NASDAQ:PPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts